Could a single nasal spray protect us from viruses and allergens alike?

Science · Published 8 October 2026 Swipe more like this →

In short: Researchers have developed a vaccine in mice that targets a remarkably wide spectrum of respiratory threats. This new approach moves beyond traditional antigen specificity to offer broad protection against viruses, bacteria, and even common allergens, potentially replacing the need for multiple seasonal jabs if successfully translated to humans.

In a study published in February 2024 in the journal Science, researchers from Stanford Medicine and their collaborators achieved a significant milestone in vaccine development. By using an intranasal delivery method, similar to a nasal spray, they created a formula that provides broad protection in the lungs for several months. This approach is particularly striking because it moves toward a 'universal' vaccine, a concept that has long been considered a 'pie-in-the-sky' idea in immunology. This research was led by senior author Bali Pulendran, a professor of microbiology and immunology. The study's primary investigator was postdoctoral scholar Haibo Zhang.

The vaccine's efficacy was demonstrated in mice against a diverse array of pathogens. The study showed protection against SARS-CoV-2 and other coronaviruses, as well as Staphylococcus aureus and Acinetobacter baumannii—both of which are common hospital-acquired infections. Remarkably, the vaccine also protected against house dust mites, a frequent allergen. This multi-purpose capability is a departure from the standard principle of antigen specificity, where vaccines typically mimic a specific component of a single pathogen to train the immune system. This broad-spectrum efficacy was confirmed through testing against various respiratory threats. The results suggest a significant departure from current immunological methods.

While most universal vaccine attempts aim to cover an entire family of viruses by targeting conserved components that resist mutation, this new formula targets multiple types of threats simultaneously. If this technology can be successfully translated into human applications, it could fundamentally change public health. It could potentially replace the need for multiple annual injections for seasonal respiratory infections and provide a ready defense should a new pandemic virus emerge.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• A single shot might one day protect against all respiratory germs
• Can we finally develop a universal flu vaccine that targets every single strain?
• Beyond the headlines, vaccines are a dynamic field of history and cutting-edge science.
• The complex calculus behind deciding which diseases deserve a vaccine
• Could a simple smear of Vaseline stop the next deadly viral pandemic?
• How mobile education is reshaping the modern classroom
• Why scientists occasionally build treadmills for shrimp
• The silent expansion of the body's main oxygen highway
• Mastering the Digital Classroom: A Guided Tour of Google Meet
• How a $200 experiment became a viral headline about mask safety
• The aerodynamic assumption that once held supersonic flight back
• Why some infinite sums only work if you keep their signs

More in Science · Latest · A–Z · All topics